DEA official resigns amid reports of previous Big Pharma consulting work

The DEA's second-in-command has quietly stepped down amid reporting that he once consulted for the opioid drugmaker Purdue Pharma.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...